热门资讯> 正文
P3 Health Partners reports Q1 results
2024-05-09 05:22
- P3 Health Partners press release (NASDAQ:PIII): Q1 net loss was $49.6 million compared to a net loss of $52.4 million in the first quarter of the prior year.
- Total revenue was $388.5 million, an increase of 29% compared to $302.1 million in the first quarter of the prior year.
- Company anticipates reaching adjusted EBITDA positive in 2024.
-
Fiscal 2024 Guidance |
| |
| |
|
Year Ended December 31, 2024 |
| |
|
Low |
High |
At-Risk Members(2) |
|
|
125,000 |
|
|
135,000 |
|
Total Revenues (in millions) |
|
$ |
1,450 |
|
$ |
1,550 |
|
Medical Margin(1)(3) (in millions) |
|
$ |
230 |
|
$ |
250 |
|
Medical Margin(3) PMPM |
|
$ |
165 |
|
$ |
175 |
|
Adjusted EBITDA(3) (in millions) |
|
$ |
20 |
|
$ |
40 |
More on P3 Health Partners
- P3 Health Partners Inc. (PIII) Q4 2023 Earnings Call Transcript
- P3 Health Partners just downgraded at BTIG
- Seeking Alpha’s Quant Rating on P3 Health Partners
- Historical earnings data for P3 Health Partners
- Financial information for P3 Health Partners
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。